According to IMARC Group’s latest report, titled “Asia Pacific Dry Eye Syndrome Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.’ the Asia Pacific dry eye syndrome market is expected to exhibit a CAGR of X% during 2022-2027. Dry eye syndrome is a medical ailment that is caused due to the lack of water and moisture on the surface of the eyes. It is caused due to multiple factors, including excessive screen time, autoimmune disorders, allergies, vitamin deficiency and menopause. It is a chronic disorder that is characterized by various symptoms, such as discomfort, photophobia, aching, burning, pain, redness and irritation in the eyes. Dry eye syndrome can generally be treated by anti-inflammatory drugs, liquid tear drops, gels, eye ointment, surgeries, and autologous serum eye drops.
We are constantly tracing and assessing the impact of the COVID-19 pandemic on the industry. These influences have been covered in our report as significant market contributors.
Request for a PDF sample of this report: https://www.imarcgroup.com/asia-pacific-dry-eye-syndrome-market/requestsample
The Asia pacific dry eye syndrome market is primarily driven by the rising geriatric population that is prone to develop various chronic diseases. Moreover, the widespread utilization of hyaluronic acid in eye drops as a moisture-retaining agent to effectively treat dry eye syndrome is providing an impetus to the market growth. In line with this, the proliferation of smart devices has further resulted in excessive screen time, which is favoring the market growth. Other factors, including rising pollution levels across the region and significant improvements in the healthcare industry, are also anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Asia Pacific dry eye syndrome market, along with forecasts at the country and regional level from 2022-2027. Our report has categorized the market based on disease type, drug type, product and distribution channel.
Breakup by Disease Type:
- Evaporative Dry Eye Syndrome
- Aqueous Dry Eye Syndrome
Breakup by Drug Type:
- Anti-inflammatory Drugs
- Lubricant Eye Drops
- Autologous Serum Eye Drops
Breakup by Product:
- Liquid Drops
- Liquid Wipes
- Eye Ointment
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Breakup by Country:
- South Korea
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/asia-pacific-dry-eye-syndrome-market
Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800